Protein,Protein_definition,Disease_category,Disease,NB_individual,NB_case,HR[95%CI],P_value
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter I Certain infectious and parasitic diseases,"Other viral diseases, not elsewhere classified",24068,138,1.17 [1.01-1.36],0.042514391726822
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter I Certain infectious and parasitic diseases,Streptococcus and staphylococcus as the cause of diseases classified to other chapters,23268,299,1.12 [1.01-1.24],0.0369622417006622
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter II Neoplasms,Benign lipomatous neoplasm,23923,275,1.16 [1.04-1.30],0.0062342980963808
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter II Neoplasms,Benign lipomatous neoplasm of skin and subcutaneous tissue of trunk,24070,65,1.32 [1.06-1.64],0.014380029138148
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter II Neoplasms,Benign neoplasm: Descending colon,24165,153,0.85 [0.73-0.98],0.0288390898247044
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter II Neoplasms,Carcinoma in situ of breast,11399,77,0.81 [0.66-0.99],0.0396765156118911
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of calcium metabolism,20735,163,1.16 [1.01-1.33],0.0401004980263104
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of lipoprotein metabolism and other lipidaemias,22664,2092,1.07 [1.03-1.11],0.0005564503362658
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of other endocrine glands,24085,229,1.13 [1.01-1.27],0.0399715937824967
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of parathyroid gland,23949,93,1.26 [1.05-1.52],0.0134221176580235
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of the thyroid gland,23800,1116,1.06 [1.00-1.12],0.0342508103225955
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperparathyroidism,23943,87,1.25 [1.03-1.52],0.0209785293548887
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Metabolic disorders,23559,2987,1.06 [1.02-1.09],0.0009932981863158
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Phobic anxiety disorders,22907,98,1.21 [1.01-1.44],0.0398519542399783
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter IX Diseases of the circulatory system,Coronary atherosclerosis,23525,1175,1.06 [1.01-1.12],0.024802788800266
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter IX Diseases of the circulatory system,"Hypertension, portal",24013,47,0.75 [0.58-0.99],0.0388814604668807
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter IX Diseases of the circulatory system,"Ischaemic heart disease, wide definition",23674,1314,1.06 [1.00-1.11],0.0318276263599126
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter IX Diseases of the circulatory system,Oesophageal varices,23037,29,0.68 [0.48-0.95],0.0248815232630183
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,24115,121,0.85 [0.72-1.00],0.0452149746606349
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other cataract,23549,947,1.07 [1.01-1.14],0.0195445020850068
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Retinal detachment with retinal break,23627,109,1.25 [1.05-1.48],0.0115172712551488
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter X Diseases of the respiratory system,Allergic rhinitis,24045,283,1.15 [1.03-1.27],0.0113925400267925
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter X Diseases of the respiratory system,Other diseases of pleura,24011,1097,1.06 [1.01-1.12],0.0307715217099218
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter X Diseases of the respiratory system,Other diseases of upper respiratory tract,23595,790,1.07 [1.01-1.14],0.0309367660118349
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter X Diseases of the respiratory system,Other respiratory disorders and diseases,24097,746,1.08 [1.01-1.15],0.0242945094756075
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter X Diseases of the respiratory system,Pollen allergy,24142,243,1.13 [1.01-1.27],0.0317698571917149
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter X Diseases of the respiratory system,Vasomotor and allergic rhinitis,23088,283,1.15 [1.03-1.28],0.0106417629172199
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XI Diseases of the digestive system,"Cirrhosis of liver, NAS",24039,73,0.80 [0.65-0.99],0.0442477716494414
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XI Diseases of the digestive system,"Diseases of oral cavity, salivary glands and jaws",23743,539,1.08 [1.00-1.17],0.0433173112942739
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XI Diseases of the digestive system,Embedded and impacted teeth,24055,71,1.30 [1.06-1.61],0.0128313870863467
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XI Diseases of the digestive system,Impacted teeth,24064,66,1.36 [1.09-1.69],0.0053763888394305
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XI Diseases of the digestive system,Oesophageal obstruction,19373,129,1.30 [1.11-1.53],0.0010355461096533
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XI Diseases of the digestive system,Oesophagitis,19676,432,1.11 [1.02-1.21],0.0211428531943408
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XI Diseases of the digestive system,Other inflammatory liver diseases,23485,71,0.76 [0.61-0.94],0.0131809051474716
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XI Diseases of the digestive system,Palatinal maxillary canine,24039,84,1.23 [1.02-1.49],0.0333099398718832
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified disorders of skin and subcutaneous tissue,23012,259,1.17 [1.05-1.31],0.0056296482157946
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified psoriasis,23996,134,0.80 [0.69-0.94],0.0061999883399068
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XII Diseases of the skin and subcutaneous tissue,"Other disorders of skin and subcutaneous tissue, not elsewhere classified",23040,287,1.19 [1.07-1.32],0.0012000913586239
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Fibroblastic disorders,21265,206,1.16 [1.02-1.31],0.0214940681268458
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Fibromyalgia,21317,258,1.13 [1.01-1.26],0.0326459824902107
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Hallux valgus (acquired),18760,307,0.90 [0.81-1.00],0.0443966713007805
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Palmar fascial fibromatosis [Dupuytren],21212,153,1.17 [1.01-1.35],0.0380426671688883
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XIV Diseases of the genitourinary system,Benign mammary dysplasia,13026,70,0.79 [0.64-0.98],0.0326745508289848
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XIV Diseases of the genitourinary system,Calculus of lower urinary tract,23688,55,0.78 [0.61-0.99],0.0446625820884572
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XIV Diseases of the genitourinary system,Chronic nephritic syndrome,24012,20,0.60 [0.40-0.91],0.0153031177020131
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XIV Diseases of the genitourinary system,Hydrocele,9546,71,1.26 [1.01-1.56],0.0365383849142431
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XIV Diseases of the genitourinary system,Irregular menses,13014,107,0.76 [0.64-0.91],0.0024272446334033
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XIV Diseases of the genitourinary system,Other noninflammatory disorders of vagina,9765,53,1.30 [1.02-1.66],0.0334807300640312
